Does it matter when kidney cancer spreads?
Original title: Prognosis Comparison Between Synchronous and Metachronous Metastasis of Renal Cell Carcinoma: A Meta-Analysis and Systematic Review.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This pulls together past studies to help judge outlook, and it is not a treatment.
The short version
Kidney cancer that spreads later may have a better outlook than cancer that spread early.
What was studied. Researchers pooled results from past studies of people whose kidney cancer had spread. They compared cancer that had already spread when first found with cancer that spread later.
What they found. Across nine studies, people whose cancer spread later lived longer. This held for people on targeted drugs and for people on immune therapy. But for people whose cancer had spread to the brain, there was no clear difference.
What this means, and what it doesn't
What it could mean: If you have kidney cancer that has spread, the timing of that spread may matter. It could help doctors judge how things might go. For cancer that reached the brain, timing did not seem to matter in this study.
What it doesn't mean: This is not a new treatment, and it is not a cure. It is a review of past studies, not a new trial. It cannot tell what will happen to any one person. The authors say these results still need to be checked.
Source: PubMed, September 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.